Stantec Q2 2026 margins hit record despite revenue decline
Engineering firm reports highest-ever quarterly margins as cost controls offset lower revenue in Q2 2026.

Stantec Inc. reported record operating margins in the second quarter of 2026, even as revenue fell short of expectations due to project delays and softer demand in key markets.
The Canadian engineering and design services company disclosed in its Q2 2026 presentation slides that adjusted EBITDA margin expanded to a record high, driven by disciplined cost management and operational efficiencies. Revenue, however, declined year-over-year as prolonged approval processes and economic uncertainty weighed on project commencements in North America and international segments.
Analysts noted that while revenue headwinds persisted, the margin performance underscored Stantec’s ability to maintain profitability amid challenging conditions. The company’s backlog remained stable, providing a buffer against near-term volatility, though some analysts flagged concerns over potential further softening in discretionary spending by public and private sector clients.
Stantec did not provide specific revenue or earnings guidance in the slides, but reiterated its full-year 2026 targets, which include margin expansion and controlled capital expenditures. The firm’s focus on high-margin segments such as infrastructure, environmental services, and digital solutions continued to support profitability despite broader industry headwinds.
Shares of Stantec were little changed in pre-market trading following the release, as investors weighed the margin strength against the revenue decline. The company is scheduled to host an earnings call to discuss the results in detail later this week.
The results reflect broader trends in the engineering and construction sector, where firms are prioritizing efficiency over growth amid economic headwinds and elevated interest rates.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →

